We found that NRAS-mutant melanoma cells were significantly more resistant to the cytotoxic effects of DNA replication stress-inducing drugs compared to other genotypes (BRAF-mutant, NF1-deficient, or triple wild-type) (Figure 9A). Here, NRAS is linked to melanoma.